|
|
||||||||
Published online before print March 27, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
,
@
*The Immunomodulation Research Center, University of Ulsan, Ulsan, Korea;
Department of Pharmacology, School of Dentistry, Kyung Hee University, Seoul, Korea; and
LSU Eye Center, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA
@ To whom correspondence should be addressed. E-mail: bskwon{at}mail.ulsan.ac.kr.
| Abstract |
|---|
4-1BB (CD137) triggering typically induces Th1 response by increasing IFN-
from T cells upon TCR ligation. We found recently that 4-1BB costimulation increased the expression of IL-13 from CD4+ T cells, as well as CD8+ T cells. The enhanced IL-13 expression by agonistic anti-4-1BB treatment was mediated via MAPK1/2, PI-3K, JNK, mammalian target of rapamycin, NF-AT, and NF-
B signaling pathways. The signaling for IL-13 induction was similar to that of IFN-
production by anti-4-1BB treatment in T cells. When the anti-4-1BB-mediated IL-13 expression was tested in an in vivo viral infection model such as HSV-1 and vesicular stomatitis virus, 4-1BB stimulation enhanced IL-13 expression of CD4+ T, rather than CD8+ T cells. Although IL-13 was enhanced by anti-4-1BB treatment, the increased IL-13 did not significantly alter the anti-4-1BB-induced Th1 polarization of T cells--increase of T-bet and decrease of GATA-3. Nevertheless, anti-4-1BB treatment polarized T cells excessively in the absence of IL-13 and even became detrimental to the mice by causing liver inflammation. Therefore, we concluded that IL-13 was coinduced following 4-1BB triggering to maintain the Th1/2 balance of immune response.
Key Words: costimulation CD8+ T CD4+ T cytokine
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |